innoviva glp-1 receptor agonist weight management diabetes treatments Loss and Maintenance Related to the Mechanism of Action of Glucagon-Like Peptide 1 Agonists | Advances in Therapy New Developments in Pharmacological Treatment

a human hormone that regulates appetite and blood sugar

That translates to roughly 58 pounds of average weight loss

Weight loss drugs are approved for use in adults with a BMI of 30 or greater, or a BMI of 27 or higher with weight-related health problems like high blood pressure or type 2 diabetes

This finding supports results of several prior trials that showed GLP-1 medications reduce multiple major causes of mortality, including cardiovascular disease, kidney disease and diabetes, Mavromatis said

Lu SC, Chen M, Atangan L, et al

The effects of GLP-1RAs on prostate cancer risk Preclinical studies have demonstrated that GLP-1RAs are capable of inhibiting the proliferation of prostate cancer cells in both in vivo and in vitro experiments, thereby suggesting potential preventative effects [36]